Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

NCT04685616 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1042

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

RADIATION: Involved site radiotherapy
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Brentuximab vedotin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Haematopoietic growth factor

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]